News

Most recently, Dr Newbold was senior vice president of business development at Celldex Therapeutics. Dr Newbold holds an MBA from Columbia University and received his PhD in organic

Mr Terry is the co-founder and former director at Genomic Health, a personalized medicine company. He is also a founder of the Personalized Medicine Coalition, and co-founder and

The funding will be applied to the company’s DM-99 development program for the treatment of type 2 diabetes. Reggie Bowerman, president and CEO of DiaMedica, said: “We are

The new drug application (NDA) is supported by positive data from completed pivotal studies in which ondansetron orally dissolving film strip (ODFS) demonstrated bioequivalence against GlaxoSmithKline’s Zofran ODT

The proceeds are being used to commercialize in Europe the company’s patented m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient’s home. Cardiola’s m.pulse

The company has used part of the proceeds to acquire the PediGuard unit from SpineVision. SpineGuard was advised on both transactions by Aelios Finance. Ms Bette, chief technology

Under the agreement, Spinco will provide sales, marketing, and first-level customer support for Golden Helix’s analysis and visualization software and services. KR Kumaraswamy, vice president of life science

According to the paper, the Japanese drugmaker intends to sell the diabetes drug in these places by itself. The company plans to start selling Actos in Canada in

According to the news source, most of the job cuts are likely to involve sales personnel. The reduction also involves attrition and hiring freezes. Loss of patent protection,